Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Similar articles for PubMed (Select 10748520)

1.

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells.

Latouche JB, Sadelain M.

Nat Biotechnol. 2000 Apr;18(4):405-9.

PMID:
10748520
3.

Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.

Mangino G, Grazia Capri M, Barnaba V, Alberti S.

Int J Cancer. 2002 Oct 1;101(4):353-9.

PMID:
12209960
4.
5.
6.

Activation requirements of circulating antigen-specific human CD8(+) memory T cells probed with insect cell-based artificial antigen-presenting cells.

Guelly C, Küpcü Z, Zalusky D, Karner M, Zehetner M, Schweighoffer T.

Eur J Immunol. 2002 Jan;32(1):182-92.

PMID:
11754359
7.
8.

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1.

Cooper LJ, Al-Kadhimi Z, Serrano LM, Pfeiffer T, Olivares S, Castro A, Chang WC, Gonzalez S, Smith D, Forman SJ, Jensen MC.

Blood. 2005 Feb 15;105(4):1622-31. Epub 2004 Oct 26.

9.

Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.

Papanicolaou GA, Latouche JB, Tan C, Dupont J, Stiles J, Pamer EG, Sadelain M.

Blood. 2003 Oct 1;102(7):2498-505. Epub 2003 Jun 12.

10.

A triad of costimulatory molecules synergize to amplify T-cell activation in both vector-based and vector-infected dendritic cell vaccines.

Schlom J, Sabzevari H, Grosenbach DW, Hodge JW.

Artif Cells Blood Substit Immobil Biotechnol. 2003 May;31(2):193-228.

PMID:
12751840
11.

The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells.

zum Büschenfelde CM, Metzger J, Hermann C, Nicklisch N, Peschel C, Bernhard H.

J Immunol. 2001 Aug 1;167(3):1712-9.

12.

Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.

Xiaobing J, Xiaoling L, Ruen L, Fangcheng Z, Hongyang Z.

Cancer Biother Radiopharm. 2007 Dec;22(6):826-35.

PMID:
18158774
13.

Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Oosten LE, Blokland E, van Halteren AG, Curtsinger J, Mescher MF, Falkenburg JH, Mutis T, Goulmy E.

Blood. 2004 Jul 1;104(1):224-6. Epub 2004 Mar 18.

14.

Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.

Schilbach K, Kerst G, Walter S, Eyrich M, Wernet D, Handgretinger R, Xie W, Rammensee HG, Müller I, Bühring HJ, Niethammer D.

Blood. 2005 Jul 1;106(1):144-9. Epub 2005 Feb 24.

15.

Selection of HLA-A2 restricted CML28 peptide by artificial antigen-presenting cells.

Mao H, Geng Z, Liu W, Sun H, Huang W.

J Immunother. 2008 Jun;31(5):487-90. doi: 10.1097/CJI.0b013e318176facc.

PMID:
18463536
16.

Enhancing the potency of peptide-pulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules.

Hodge JW, Grosenbach DW, Rad AN, Giuliano M, Sabzevari H, Schlom J.

Vaccine. 2001 May 14;19(25-26):3552-67.

PMID:
11348723
19.

Peptide-beta2-microglobulin-major histocompatibility complex expressing cells are potent antigen-presenting cells that can generate specific T cells.

Obermann S, Petrykowska S, Manns MP, Korangy F, Greten TF.

Immunology. 2007 Sep;122(1):90-7. Epub 2007 Apr 30.

20.

Lentiviral vectors encoding HIV-1 polyepitopes induce broad CTL responses in vivo.

Iglesias MC, Mollier K, Beignon AS, Souque P, Adotevi O, Lemonnier F, Charneau P.

Mol Ther. 2007 Jun;15(6):1203-10. Epub 2007 Mar 20.

PMID:
17375069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk